In today’s briefing:
- FTSE China A50 Index Rebalance Preview: PetroChina & EVE Energy Are Potential Adds
- FTSE China 50 Index Rebalance Preview: Yankuang Energy (1171) Could Replace Shenzhou Intl (2313)
- Biocytogen (百奥赛图) IPO: Short Term and Long Term Challenges
- Swire Buyback Update – It’s On, and Regulatorily Constrained
- Shanghai/Shenzhen Southbound Connect: Weekly Moves (22 August 2022)
- Shanghai/Shenzhen Northbound Connect: Weekly Moves (22 August 2022)
- Orient Overseas Intl (316 HK): Don’t Overlook the Downhill Risks
- BeiGene (6160.HK/BGNE.US) 22H1- It Is an Indisputable Fact that BeiGene Is Difficult to Make Profits
- WM Motor Holding IPO – The Positives – Fast Growth Driven by Its SUV and Mainstream Focus
- Morning Views Asia: Golden Eagle Retail, KWG Living Group
FTSE China A50 Index Rebalance Preview: PetroChina & EVE Energy Are Potential Adds
- PetroChina (601857 CH) and EVE Energy (300014 CH) could replace China Pacific Insurance (Group) (601601 CH) and Zhangzhou Pientzehuang Pharmaceutical Co. (600436 CH) in the index at the September rebalance.
- Assuming both changes are implemented, estimated one-way turnover is 2.24% and will result in a one-way trade of CNY 1,180m.
- There has been no announcement from FTSE yet on the potential increase in the number of index constituents from 50 to 100.
FTSE China 50 Index Rebalance Preview: Yankuang Energy (1171) Could Replace Shenzhou Intl (2313)
- Yankuang Energy Group (1171 HK) is the highest ranked eligible non-constituent and could replace Shenzhou Intl Group Holdings (2313 HK) in the index at the September rebalance.
- Passive trackers will need to buy over 1 day of ADV on Yankuang Energy Group (1171 HK) while selling over 1 days ADV on Shenzhou Intl Group Holdings (2313 HK).
- Short interest is over 10% of float on Yankuang Energy Group (1171 HK) and there could be short covering as the stock breaks out.
Biocytogen (百奥赛图) IPO: Short Term and Long Term Challenges
- Biocytogen is a leading animal model player in China expanding into biotech. The company launched a downsized deal to raise up to USD 70m via a Hong Kong listing.
- In our previous note, we looked at the company business lines and compared the company’s operation with leading animal model players.
- In this note, we provide an update for the book building. We provide our quick thoughts on the valuation and deal dynamics.
Swire Buyback Update – It’s On, and Regulatorily Constrained
- And on the 6th Day, Swire Pacific (A) (19 HK) commenced its buyback.
- It took until the 6th day for Swire to start its buyback, and now that it has started, we may have a little better idea of the parameters. And impact.
- So far, they appear to be bending the rules a little, but it is still the way it should be. So there is still a trade here to do.
Shanghai/Shenzhen Southbound Connect: Weekly Moves (22 August 2022)
- Inside is a recap of movements in the last week relating to the Shanghai and Shenzhen-Hong Kong Stock Connect facilities, broken down by company and industry.
- Overall, the net outflow over the past week was ~US$0.21bn, split (-US$0.24bn) for Shanghai and (+US$0.3bn) for Shenzhen.
- The largest inflows were into China International Marine (2039 HK) and Li Ning (2331 HK). The largest outflows were in Meituan (3690 HK)and Kuaishou Technology (1024 HK).
Shanghai/Shenzhen Northbound Connect: Weekly Moves (22 August 2022)
- Inside is a recap of movements in the last week relating to the Hong Kong Stock Exchange -Shanghai and Shenzhen Northbound Connect facilities, broken down by company and industry.
- Overall, net inflow over the past week was ~US$1.2bn, split between Shanghai (US$0.9bn) and Shenzhen (US$0.3bn).
- The largest inflows were into CATL (300750 CH) and Hundsun Technologies (600570 CH). The largest outflows were in TBEA Co Ltd A (600089 CH) and Tongwei Co Ltd (600438 CH).
Orient Overseas Intl (316 HK): Don’t Overlook the Downhill Risks
- 1H22 is a fantastic period for Orient Overseas International (316 HK) with record earnings. However, with retreat in freight rates YTD, it is likely to mark the cycle peak.
- OOIL has not seen the usual peak season for transpacific market yet. Also, supply pressure is mounting as record vessel delivery is scheduled for the next two years.
- The elevated share price has not reflected that profitability will decline in FY23 and FY24. We see significant downside risk as the market becomes more realistic on earnings.
BeiGene (6160.HK/BGNE.US) 22H1- It Is an Indisputable Fact that BeiGene Is Difficult to Make Profits
- BeiGene’s product sales in 2022H1 more than doubled YoY, which was a positive sign for commercialization. However, net loss further widened, mainly due to significantly high R&D and SG&A expenses.
- Tislelizumab and zanubrutinib are not enough to support BeiGene’s high valuation. The success or failure of TIGIT project will be the key to determine how far BeiGene will go.
- So far, it is still an indisputable fact that BeiGene has profitability issues. That’s why it’s hard for us to be optimistic about this company.
WM Motor Holding IPO – The Positives – Fast Growth Driven by Its SUV and Mainstream Focus
- WM Motor Technology Co Ltd (WMT CH) (WMM) is looking to raise about US$1bn in its upcoming Hong Kong IPO.
- WM Motor is a smart EV player in China. As of the latest practicable date, it had a total of four main EV models.
- In this note, we talk about the positive aspects of the deal.
Morning Views Asia: Golden Eagle Retail, KWG Living Group
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars